Venture Partner

Email

 

Phil Reilly joined Third Rock Ventures in 2009, and supports the firm’s founding and advancement of new ventures, with a particular focus on seeking to nurture and grow transformational companies dedicated to breakthrough treatments for genetic disorders. Phil is an accomplished entrepreneur, and has a long standing interest in genetic testing and in developing new therapies for genetic diseases.

Phil holds an MD from Yale University, a JD from Columbia University and is a member of the Massachusetts Bar and board certified in internal medicine and clinical genetics. He is currently a trustee of Cornell University. Phil has also served twice (2000 & 2003) as President of the American Society of Law, Medicine, and Ethics. He also served on the Board of Directors of the American Society for Human Genetics. Phil has also held numerous teaching positions at Tufts University School of Medicine, Harvard Medical School, Cornell University and adjunct professor of both legal studies and biology at Brandeis University.

Current Roles

• Board Member of Edimer Pharmaceuticals

Year Joined Third Rock

• 2009

Administrative Support

• Zoë Holt Angell
  Executive Assistant
  Email
  (617) 585-2030

Venture Partner

Email

 

Greg Verdine joined Third Rock Ventures in 2009, and provides scientific due diligence for the firm’s potential portfolio investments.  Greg is a thought leader in the field of chemical biology and an accomplished drug discovery entrepreneur.

 

Greg currently serves as the Director of the Chemical Biology Initiative and the Program in Cancer Chemical Biology at the Dana-Farber Cancer Institute, and is the Erving Professor of Chemistry at Harvard University.

Prior to joining Third Rock Ventures, Greg co-founded a number of biotechnology companies in addition to serving as a founding scientific advisor to Vertex Pharmaceuticals and Variagenics, Inc.

Greg holds a PhD in Chemistry from Columbia University, a BS in Chemistry from St. Joseph’s University, and served as a NIH Postdoctoral Fellow in Molecular Biology at MIT and Harvard Medical School. He is currently a Scientific Advisor to the Board of Directors of the Ibusuki Medipolis Research Institute; the Bill and Melinda Gates Foundation; the Board of Scientific Consultants of the Memorial Sloan Kettering Research Institute; and the Scientific Advisory Board of the SMA Foundation.

Year Joined Third Rock

• 2009

Administrative Support

• Elizabeth Donovan
  Email
  (617) 495-9744